Harrell Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Harrell Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-363	Closed	-$204K	–	149
2026 Q1	$204K	Hold	363	–	–	0.05%	142
2025 Q4	$246K	Hold	363	–	–	0.06%	118
2025 Q3	$232K	Buy	+363	New	+$220K	0.05%	118
2024 Q4	–	Sell	-588	Closed	-$297K	–	93
2024 Q3	$297K	Hold	588	–	–	0.08%	82
2024 Q2	$286K	Hold	588	–	–	0.08%	85
2024 Q1	$317K	Hold	588	–	–	0.09%	80
2023 Q4	$326K	Hold	588	–	–	0.1%	81
2023 Q3	$253K	Hold	588	–	–	0.09%	91
2023 Q2	$295K	Hold	588	–	–	0.1%	81
2023 Q1	$240K	Hold	588	–	–	0.09%	89
2022 Q4	$240K	Buy	+588	New	+$228K	0.09%	89
2022 Q3	–	Sell	-588	Closed	-$206K	–	94
2022 Q2	$206K	Sell	588 -62	-10%	-$25.3K	0.08%	92
2022 Q1	$356K	Hold	650	–	–	0.13%	86
2021 Q4	$428K	Hold	650	–	–	0.13%	79
2021 Q3	$404K	Hold	650	–	–	0.13%	83
2021 Q2	$411K	Hold	650	–	–	0.13%	81
2021 Q1	$318K	Buy	+650	New	+$326K	0.11%	88

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Harrell Investment Partners's IDXX Position: Q2 2026 in Review

Harrell Investment Partners sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 363 shares — an estimated $204K sold.

Harrell Investment Partners first reported a position in IDXX in Q1 2021 and held it in 17 quarters. The position peaked at $428K in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Harrell Investment Partners reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
Harrell Investment Partners sold 363 Idexx Laboratories shares in Q2 2026, an estimated $204K.
Harrell Investment Partners first reported a position in Idexx Laboratories in Q1 2021 and held it in 17 quarters.
Harrell Investment Partners's Idexx Laboratories position peaked at $428K in Q4 2021.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Harrell Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.